
Targeted Therapeutic Solutions LLC (AKA: TTS) Profile last edited on: 6/29/15
CAGE: 6LDD2
UEI:
Business Identifier: Anticoagulant therapy Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
3160 Chestnut Street Suite 200
Philadelphia, PA 19104
Philadelphia, PA 19104
(267)-294-5164 |
N/A |
N/A |
Location: Single
Congr. District: 03
County: Philadelphia
Congr. District: 03
County: Philadelphia
Public Profile
Targeted Therapeutic Solutions LLC ("TTS"), is developing a unique agent that can potentially reduce the incidence of stroke and its associated maladies. This therapeutic approach has the potential for reducing bleeding risk than existing clinical agents, making this technology useful for patients with or at risk for pulmonary embolism, deep vein thrombosis and certain types of heart attacks.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2013 | 1 | NIH | $239,505 | |
Project Title: Development of a First-In-Class Targeted Fibrinolytic for Post-Surgical Thrombopr |
Key People / Management
Ronald Carnemolla
Company News
There are no news available.